Preterm Birth May Increase Risk for Type 1 and Type 2 Diabetes
The risk for type 1 and type 2 diabetes from childhood into adulthood is increased in preterm-born individuals.
Type 1 Diabetes
Type 1 Diabetes May Increase Progression of Coronary Artery Calcium During Menopause
For women going through menopause, type 1 diabetes is associated with higher coronary artery calcium volume and accelerated progression of CAC over time.
Insulin Glargine 300 U/mL Approved for Pediatric Patients With Diabetes
The FDA has expanded the indication for Toujeo (insulin glargine; Sanofi) 300 Units/mL to include treatment of pediatric patients aged ≥6 years with diabetes mellitus.
Examining Changes in BMI From Childhood to Puberty in Type 1 Diabetes
The high prevalence of overweight and obesity in youth with T1D was consistent across a multinational cohort and persistent over time.
Alarm Settings of CGM Systems Affect Glucose Control in T1D
Adjusting glucose thresholds for hypoglycemia and hyperglycemia alarms in continuous glucose monitoring can help achieve better glucose control in patients with type 1 diabetes.
FDA Advisory Committee Votes Against Empagliflozin for Type 1 Diabetes
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) voted 14 to 2 against the approval of empagliflozin 2.5 mg as an adjunct to insulin for adults with type 1 diabetes.
Medicaid Expansion Has a Positive Impact on Diabetes Management
Medicaid expansion under the Affordable Care Act was found to improve self-reported diabetes management and self-reported health outcomes in patients with type 1 or type 2 diabetes.
Topical Wound Oxygen Therapy Improves Healing of Diabetic Foot Ulcers
Combination of cyclical pressure Topical Wound Oxygen (TWO2) therapy with optimal standard of care improves healing and can reduce recurrence of diabetic foot ulcer.
Closed-Loop System Better Controls Blood Glucose Than Sensor-Augmented Insulin Pump
A closed-loop insulin delivery system, also referred to as an artificial pancreas, was found to be more effective than sensor-augmented insulin pump therapy in patients with type 1 diabetes.
Fast-Acting Insulin Approved for Use in Insulin Infusion Pumps
The FDA has expanded the indication for Fiasp (insulin aspart injection; Novo Nordisk) 100 Units/mL to include use in insulin infusion pumps to improve glycemic control in adults with type 1 or type 2 diabetes.
Next post in Diabetes
